Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
Market Information
Since September 10, 2013, the Company’s shares of common stock have traded on the NYSE American under the ticker symbol “ PED. ”
Stockholders
As of March 27, 2026, there were 13,300,621 shares of our common stock issued and outstanding held by approximately 148 holders of record of our common stock, not including any persons who hold their stock in “ street name ”.
Dividend Policy
We do not currently intend to pay any cash dividends on our common stock in the foreseeable future. We expect to retain all available funds and future earnings, if any, to fund the development and growth of our business. Any future determination to pay dividends, if any, on our common stock will be at the discretion of our Board of Directors and will depend on, among other factors, our results of operations, financial condition, capital requirements and contractual restrictions.
Common Stock
The Company is authorized to issue 300,000,000 shares of common stock with $0.001 par value per share. Holders of shares of common stock are entitled to one vote per share on each matter submitted to a vote of stockholders. In the event of liquidation, holders of common stock are entitled to share pro rata in the distribution of assets remaining after payment of liabilities, if any. Holders of common stock have no cumulative voting rights, and, accordingly, the holders of a majority of the outstanding shares have the ability to elect all of the directors of the Company. Holders of common stock have no preemptive or other rights to subscribe for shares. Holders of common stock are entitled to such dividends as may be declared by the Board out of funds legally available, therefore. The outstanding shares of common stock are validly issued, fully paid and non-assessable.
Preferred Stock
At December 31, 2025, the Company was authorized to issue 100,000,000 shares of preferred stock with a par value of $0.001 per share, of which 25,000,000 shares were designated “Series A Convertible Preferred Stock”. As of December 31, 2025, and 2024, there were 17,013,637 and 0 shares of the Company’s Series A Convertible Preferred Stock outstanding, respectively. On February 27, 2026, the 17,013,637 outstanding shares of Series A Convertible Preferred Stock were automatically converted into 8,506,818 shares of common stock (see “ Item 8. Financial Statements and Supplementary Data ” - “ Note 19 - Subsequent Events ”). As a result, there are no outstanding shares of preferred stock as of the date of this filing.
Additionally, on February 27, 2026, the Company, after approval of the Board of Directors and the stockholders pursuant to the Written Consent, filed a Second Amended and Restated Certificate of Formation of the Company, which among other things, terminated the designation of the Series A Preferred Stock. As such, as of the date of this Report, we have no Series A Preferred Stock outstanding or designated.
Stock Transfer Agent
Our stock transfer agent is Equiniti Trust Company, LLC located at 48 Wall Street, Floor 23 New York, NY 10005.
82
Table of Contents
Recent Sales of Unregistered Securities
There have been no sales of unregistered securities during the quarter ended December 31, 2025 and from the period from January 1, 2026 to the filing date of this report, which have not previously been disclosed in a Quarterly Report on Form 10-Q or in a Current Report on Form 8-K.
Purchases of Equity Securities by The Issuer and Affiliated Purchasers
None.
ITEM 6. [RESERVED]
83
Table of Contents